KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Equity Average (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Equity Average for 4 consecutive years, with $1.4 billion as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Equity Average fell 8.62% year-over-year to $1.4 billion, compared with a TTM value of $1.4 billion through Sep 2023, down 8.62%, and an annual FY2022 reading of $1.7 billion, up 62.15% over the prior year.
  • Equity Average was $1.4 billion for Q3 2023 at Ginkgo Bioworks Holdings, down from $1.6 billion in the prior quarter.
  • Across five years, Equity Average topped out at $1.7 billion in Q1 2023 and bottomed at $375.7 million in Q2 2021.
  • Average Equity Average over 4 years is $1.2 billion, with a median of $1.5 billion recorded in 2022.
  • The sharpest move saw Equity Average soared 324.77% in 2022, then fell 8.62% in 2023.
  • Year by year, Equity Average stood at $493.2 million in 2020, then surged by 222.93% to $1.6 billion in 2021, then decreased by 0.16% to $1.6 billion in 2022, then dropped by 13.33% to $1.4 billion in 2023.
  • Business Quant data shows Equity Average for DNA at $1.4 billion in Q3 2023, $1.6 billion in Q2 2023, and $1.7 billion in Q1 2023.